184 related articles for article (PubMed ID: 26197057)
1. Monitoring Cerebrovascular Reactivity through the Use of Arterial Spin Labeling in Patients with Moyamoya Disease.
Yun TJ; Paeng JC; Sohn CH; Kim JE; Kang HS; Yoon BW; Choi SH; Kim JH; Lee HY; Han MH; Zaharchuk G
Radiology; 2016 Jan; 278(1):205-13. PubMed ID: 26197057
[TBL] [Abstract][Full Text] [Related]
2. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
[TBL] [Abstract][Full Text] [Related]
3. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease.
Ukai R; Mikami T; Nagahama H; Wanibuchi M; Akiyama Y; Miyata K; Mikuni N
J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105058. PubMed ID: 32807463
[TBL] [Abstract][Full Text] [Related]
4. Monitoring Cerebral Perfusion Changes after Revascularization in Patients with Moyamoya Disease by Using Arterial Spin-labeling MR Imaging.
Lee S; Yun TJ; Yoo RE; Yoon BW; Kang KM; Choi SH; Kim JH; Kim JE; Sohn CH; Han MH
Radiology; 2018 Aug; 288(2):565-572. PubMed ID: 29714677
[TBL] [Abstract][Full Text] [Related]
5. Comparison of CBF Measured with Combined Velocity-Selective Arterial Spin-Labeling and Pulsed Arterial Spin-Labeling to Blood Flow Patterns Assessed by Conventional Angiography in Pediatric Moyamoya.
Bolar DS; Gagoski B; Orbach DB; Smith E; Adalsteinsson E; Rosen BR; Grant PE; Robertson RL
AJNR Am J Neuroradiol; 2019 Nov; 40(11):1842-1849. PubMed ID: 31694821
[TBL] [Abstract][Full Text] [Related]
6. Arterial spin-labeling magnetic resonance imaging after revascularization of moyamoya disease.
Sugino T; Mikami T; Miyata K; Suzuki K; Houkin K; Mikuni N
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):811-6. PubMed ID: 22721824
[TBL] [Abstract][Full Text] [Related]
7. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
Goetti R; Warnock G; Kuhn FP; Guggenberger R; O'Gorman R; Buck A; Khan N; Scheer I
AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
[TBL] [Abstract][Full Text] [Related]
8. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of 3D arterial spin-labeled brain perfusion imaging for Alzheimer disease: comparison with brain perfusion SPECT.
Takahashi H; Ishii K; Hosokawa C; Hyodo T; Kashiwagi N; Matsuki M; Ashikaga R; Murakami T
AJNR Am J Neuroradiol; 2014 May; 35(5):906-11. PubMed ID: 24263694
[TBL] [Abstract][Full Text] [Related]
10. Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in Patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI.
Mandell DM; Han JS; Poublanc J; Crawley AP; Stainsby JA; Fisher JA; Mikulis DJ
Stroke; 2008 Jul; 39(7):2021-8. PubMed ID: 18451352
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with
Hara S; Tanaka Y; Ueda Y; Hayashi S; Inaji M; Ishiwata K; Ishii K; Maehara T; Nariai T
AJNR Am J Neuroradiol; 2017 Apr; 38(4):696-702. PubMed ID: 28209582
[TBL] [Abstract][Full Text] [Related]
12. Can combined high-resolution vessel wall imaging and multiple post-labeling delay 3D pseudo-continuous arterial spin labeling differentiate moyamoya disease from atherosclerotic moyamoya syndrome?
Guo Y; Dou W; Wang X; Wang X; Mao H; Chen K
Eur J Radiol; 2023 Dec; 169():111184. PubMed ID: 37931375
[TBL] [Abstract][Full Text] [Related]
13. A novel application of four-dimensional magnetic resonance angiography using an arterial spin labeling technique for noninvasive diagnosis of Moyamoya disease.
Uchino H; Ito M; Fujima N; Kazumata K; Yamazaki K; Nakayama N; Kuroda S; Houkin K
Clin Neurol Neurosurg; 2015 Oct; 137():105-11. PubMed ID: 26185929
[TBL] [Abstract][Full Text] [Related]
14. Relationships between hypercarbic reactivity, cerebral blood flow, and arterial circulation times in patients with moyamoya disease.
Donahue MJ; Ayad M; Moore R; van Osch M; Singer R; Clemmons P; Strother M
J Magn Reson Imaging; 2013 Nov; 38(5):1129-39. PubMed ID: 23440909
[TBL] [Abstract][Full Text] [Related]
15. Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan.
Mugikura S; Fujimura M; Takahashi S
Radiology; 2016 May; 279(2):652-3. PubMed ID: 27089195
[No Abstract] [Full Text] [Related]
16. Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.
Ladner TR; Donahue MJ; Arteaga DF; Faraco CC; Roach BA; Davis LT; Jordan LC; Froehler MT; Strother MK
J Neurosurg; 2017 Feb; 126(2):495-503. PubMed ID: 26967789
[TBL] [Abstract][Full Text] [Related]
17. High Intravascular Signal Arterial Transit Time Artifacts Have Negligible Effects on Cerebral Blood Flow and Cerebrovascular Reserve Capacity Measurement Using Single Postlabel Delay Arterial Spin-Labeling in Patients with Moyamoya Disease.
Fahlström M; Lewén A; Enblad P; Larsson EM; Wikström J
AJNR Am J Neuroradiol; 2020 Mar; 41(3):430-436. PubMed ID: 32115416
[TBL] [Abstract][Full Text] [Related]
18. Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.
Zheng G; Zhang LJ; Zhong J; Wang Z; Qi R; Shi D; Lu GM
Eur J Radiol; 2013 Nov; 82(11):1981-8. PubMed ID: 23849331
[TBL] [Abstract][Full Text] [Related]
19. Arterial spin-labeling MRI can identify the presence and intensity of collateral perfusion in patients with moyamoya disease.
Zaharchuk G; Do HM; Marks MP; Rosenberg J; Moseley ME; Steinberg GK
Stroke; 2011 Sep; 42(9):2485-91. PubMed ID: 21799169
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive method for mapping CVR in moyamoya disease using ASL-MRI.
Noguchi T; Kawashima M; Nishihara M; Egashira Y; Azama S; Irie H
Eur J Radiol; 2015 Jun; 84(6):1137-43. PubMed ID: 25816991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
